Navigation Links
Gene chips used to distinguish ventilator-associated pneumonia from underlying critical illness
Date:2/12/2008

St. Louis, Feb. 13, 2008 Critically ill patients who need a ventilator to breathe face a high risk of pneumonia. The lung infection, however, is exceedingly difficult to diagnose because a patient's underlying condition often skews laboratory test results and masks pneumonia's symptoms a reality that can delay appropriate antibiotic treatment.

Using gene chip technology, scientists at Washington University School of Medicine in St. Louis demonstrate for the first time they can distinguish pneumonia associated with ventilator use from other serious illnesses. The research, published Feb. 13 in the journal Public Library of Science One, suggests that the method may lead to early, more accurate detection and treatment of ventilator-associated pneumonia.

The team analyzed patterns of expression in more than 8,000 genes as patients on mechanical ventilators developed and recovered from pneumonia. They found changes in the activity of 85 genes could pinpoint early activation of the immune system in response to pneumonia, typically several days before clinical signs of the infection developed. By adding computational tools to their genomic analysis, the researchers also showed they could objectively monitor patients' recovery by graphing changes over time, creating a tool they called the "riboleukogram."

"This is an important step toward the development of a specific molecular test for diagnosing infection in particular pneumonia and predicting patients' recovery," says J. Perren Cobb, M.D., director of Washington University's Center for Critical Illness and Health Engineering and an intensivist at Barnes-Jewish Hospital. "If we could determine which patients are destined to develop pneumonia based on early changes in the activity of genes that regulate immune response, we could give them antibiotics sooner, with the hope that we might be able to prevent or curtail the infection."

As one of the more common and deadly hospital-a
'/>"/>

Contact: Caroline Arbanas
arbanasc@wustl.edu
314-286-0109
Washington University in St. Louis
Source:Eurekalert

Page: 1 2 3 4

Related biology news :

1. Princeton engineers develop low-cost recipe for patterning microchips
2. Zinc may reduce pneumonia risk in nursing home elderly
3. New thoracic imaging approach can pinpoint underlying venous problems
4. IEEE-USA commends president for asking Congress to double support for critical research
5. Diet and lifestyle critical to recovery, says study
6. Critically endangered porpoise is focus of new research report
7. Rutgers scientists research reveals critical knowledge about the nervous system
8. First-ever study: lack of critical lubricant causes wear in joints
9. Critically endangered Amur leopard captured
10. Research pioneer in the developmental origins of psychiatric illness is awarded the Sackler prize
11. Fresh-cut produce washing practices can minimize food-borne illness risks

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2009)...stant Staphylococcus Aureus ) and other drug-resi...erature plasma prototype devices have been develop...icidal cocktails. , Two prototype devices have b...ealthy skin (e.g. hands and feet) in hospitals and...reat; and another to shoot bacteria-killing agents...
(Date:11/25/2009)...duced in the stomach, may be used to boost resista...sease, Yale School of Medicine researchers report ...rnal of Neuroscience . , Parkinson,s disease is ... area of the midbrain known as the substantia nigr...Reduced production of dopamine in late-stage Parki...
(Date:11/25/2009)...ighters, police officers and ambulance workers fac...enter complex. They battled to save people from th...tackled fires and evacuated as many people as they...000 people. And making their jobs even harder was ...kers and their relatives jammed mobile networks wi...
Breaking Biology News(10 mins):Plasma produces KO cocktail for MRSA 2Plasma produces KO cocktail for MRSA 3Hormone ghrelin can boost resistance to Parkinson's disease 2Magic box for mission impossible 2Magic box for mission impossible 3AUDIO from Medialink and OptumHealth 3A Learn How You Can Save Money on Healthcare this One Time of Year 59101 1A School Assignment That May Add Years to a Childs Life 59096 1A School Assignment That May Add Years to a Childs Life 59096 2A School Assignment That May Add Years to a Childs Life 59096 3BD Ranked in the Top 100 Greenest Big Companies by Newsweek 3B Named Again to Dow Jones Sustainability World and North America Indexes 5311 1BD Ranked in the Top 100 Greenest Big Companies by Newsweek 3B Named Again to Dow Jones Sustainability World and North America Indexes 5311 2
... have a conversation with someone, we not only hea...older or twinkle. Gazes can be direct or shifty. “... meaning to the words we hear. , In a report to be...Autism Research in Seatlle, researchers from UCLA ... They hear and they see, of course, but the areas ...
...ity of Florida researchers have revealed how the i...es and prevents immune cells from reaching the sit...01 when letters containing the bacteria,s spores w...hed last week in the EMBO Journal, may lead to qui...se causes flu-like symptoms that can take weeks to...
...wing premature birth rate in the United States app...of pesticides and nitrates, according to work cond...cal pediatrics at the Indiana University School of...diatric Academic Societies, annual meeting, a comb...the Society for Pediatric Research, the Ambulatory...
Other Biology News:A frown or a smile? Children with autism can't discern 2Anthrax paralyzes immune cells with lethal toxin, UF research shows 2Anthrax paralyzes immune cells with lethal toxin, UF research shows 3Premature births may be linked to seasonal levels of pesticides and nitrates in surface water 2
(Date:11/24/2009)... , , Primary efficacy endpoint has been m...nt endometrial cancer, , QUEBEC CITY, Nov. 24...ASDAQ: AEZS ; TSX: AEZ) (the "Company"), a global...erapy and oncology, today announced positive effic...totoxic peptide conjugate, AEZS-108 (formerly AN-1...
(Date:11/24/2009)... , DUBLIN, November 24 /PRNewswire-First...e global specialty biopharmaceutical company, toda...opean Medicines Agency for,velaglucerase alfa, the...nt,for the treatment of Type 1 Gaucher disease. Th...erase alfa that has been submitted, with previous,...
(Date:11/24/2009)... , REDWOOD CITY, Calif., Nov. 24 /PRNewswir...X ) today announced that Randy Scott, Genomic Heal...Annual Piper Jaffray Health Care Conference in New....m. ET. ,, To access the live and subsequently...nvestor Relations section of Genomic Health,s webs...
(Date:11/24/2009)... Program Connects Customers w...les Collected with DNA Genotek Products , ...009 -- DNA Genotek , a leading provider of produc... and preparation, today announced its new global p...ancements for DNA Genotek,s partner community and ...
Breaking Biology Technology:AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 3Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 4Genomic Health to Present at Piper Jaffray Health Care Conference 2DNA Genotek Launches Global Partner Program 2DNA Genotek Launches Global Partner Program 3
...esha, Wis. - Supply-chain technology firm RedPrair...tailers who ship directly to consumers or use drop... for rules-based order sourcing called Dlx SourceR... as warehouse, transportation, process and product...companies to create inventory allocation rules bas...
...igh tech is the engine of future economic growth, ...cent study by the California-based Milken Institut...f the risk capital that technology entrepreneurs n...esses. That may soon change thanks to the recent ...yle. , ,Act 255 encourages angel investors and ven...
...anies that do not specialize in software, but inco...ocessors or microcontrollers) into their products,...rotecting that software. The software may not be t...f the product, but a feature nonetheless and a fea...mple, many vehicles, such as motorcycles, trucks a...
Other Biology Technology:An analysis of Wisconsins new venture capital and early stage finance programs 2An analysis of Wisconsins new venture capital and early stage finance programs 3Beyond the screws and gears: Protecting your products by protecting your software 2
Rabbit Anti-Human IRF7 Antibody, Unconjugated from ABR-Affinity BioReagents
Rabbit Anti-PI3K p110 delta (Poly6049) Polyclonal Antibody, Unconjugated from BioLegend
Rabbit Anti-Human Retinoic Acid-Induced 3 (RAI3 / RAIG1) Polyclonal Antibody, Unconjugated from IMGENEX
Mouse Anti-Human CD164 Antibody, Biotin Conjugated from BioLegend
Biology Products: